SEI Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

SEI Investments’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Sell	12,581 -17,611	-58%	-$543K	﹤0.01%	2642
2026 Q1	$816K	Buy	30,192 +3,399	+13%	+$114K	﹤0.01%	2448
2025 Q4	$1.15M	Sell	26,793 -33,216	-55%	-$1.25M	﹤0.01%	2125
2025 Q3	$1.7M	Buy	+60,009	New	+$1.8M	﹤0.01%	1767
2025 Q2	–	Sell	-10,302	Closed	-$185K	–	2895
2025 Q1	$185K	Buy	+10,302	New	+$209K	﹤0.01%	2483
2020 Q4	–	Sell	-6,151	Closed	-$148K	–	2523
2020 Q3	$148K	Hold	6,151	–	–	﹤0.01%	2292
2020 Q2	$113K	Hold	6,151	–	–	﹤0.01%	2308
2020 Q1	$96K	Hold	6,151	–	–	﹤0.01%	2261
2019 Q4	$132K	Buy	+6,151	New	+$127K	﹤0.01%	2318

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SEI Investments's RIGL Position: Q2 2026 in Review

SEI Investments reduced its Rigel Pharmaceuticals (RIGL) stake by 58% in Q2 2026, selling an estimated $543K and leaving 12,581 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

SEI Investments first reported a position in RIGL in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.7M in Q3 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

SEI Investments held 12,581 shares of Rigel Pharmaceuticals worth $492K as of Q2 2026.
SEI Investments sold 17,611 Rigel Pharmaceuticals shares in Q2 2026, an estimated $543K.
Rigel Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2642 holding.
SEI Investments first reported a position in Rigel Pharmaceuticals in Q4 2019 and has held it in 9 quarters since.
SEI Investments's Rigel Pharmaceuticals position peaked at $1.7M in Q3 2025.
155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.